Autolus Therapeutics plc 10-Q filing
Filed 2025-11-12 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001730463-25-000088
- Form type
- 10-Q
- CIK
- 0001730463
- Primary document
- https://www.sec.gov/Archives/edgar/data/1730463/000173046325000088/autl-20250930.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Autolus Therapeutics plc.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $51.1M | - | - |
| Cost Of Revenue | $71.0M | - | - |
| Operating Income | $-198.1M | - | - |
| Net Income | $-197.2M | - | - |
| Eps Basic | -0.74 | - | - |
| Eps Diluted | -0.74 | - | - |
| Cash And Equivalents | $86.1M | - | - |
| Total Assets | $661.9M | - | - |
| Total Liabilities | $396.5M | - | - |
| Shareholders Equity | $265.5M | - | - |
| Operating Cash Flow | $-216.2M | - | - |
| Capital Expenditures | $19.9M | - | - |